Bionovate Technologies Corp Stock Price Patterns
| BIIO Stock | USD 0.0001 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Bionovate Technologies hype-based prediction, you can estimate the value of Bionovate Technologies Corp from the perspective of Bionovate Technologies response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bionovate Technologies to buy its stock at a price that has no basis in reality. In that case, they are not buying Bionovate because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bionovate Technologies after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bionovate | Build AI portfolio with Bionovate Stock |
Bionovate Technologies After-Hype Price Density Analysis
As far as predicting the price of Bionovate Technologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bionovate Technologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bionovate Technologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bionovate Technologies Estimiated After-Hype Price Volatility
In the context of predicting Bionovate Technologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bionovate Technologies' historical news coverage. Bionovate Technologies' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Bionovate Technologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bionovate Technologies is very steady at this time. Analysis and calculation of next after-hype price of Bionovate Technologies is based on 3 months time horizon.
Bionovate Technologies Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Bionovate Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bionovate Technologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bionovate Technologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.0001 | 0.00 |
|
Bionovate Technologies Hype Timeline
Bionovate Technologies is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bionovate is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Bionovate Technologies is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 49.0% of the company shares are held by company insiders. The company last dividend was issued on the 9th of January 2020. Bionovate Technologies had 1:100 split on the 9th of January 2020. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Bionovate Technologies Basic Forecasting Models to cross-verify your projections.Bionovate Technologies Related Hype Analysis
Having access to credible news sources related to Bionovate Technologies' direct competition is more important than ever and may enhance your ability to predict Bionovate Technologies' future price movements. Getting to know how Bionovate Technologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bionovate Technologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MMTC | Micro Imaging Technology | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MOTS | Motus GI Holdings | 0.00 | 0 per month | 0.00 | 0.05 | 0.00 | 0.00 | 150.00 | |
| PROT | Proteonomix | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PJET | Priority Aviation | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ATRX | Adhera Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| UTRS | Minerva Surgical | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 980.00 | |
| ROSGQ | Rosetta Genomics | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 100.00 | |
| LITH | US Lithium Corp | 0.00 | 0 per month | 0.00 | 0.05 | 0.00 | 0.00 | 150.00 | |
| AMHD | HLK Biotech Holding | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bionovate Technologies Additional Predictive Modules
Most predictive techniques to examine Bionovate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bionovate using various technical indicators. When you analyze Bionovate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bionovate Technologies Predictive Indicators
The successful prediction of Bionovate Technologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bionovate Technologies Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bionovate Technologies based on analysis of Bionovate Technologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bionovate Technologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bionovate Technologies's related companies. | 2025 | 2026 (projected) | Interest Debt Per Share | 0.0442 | 0.042 | Revenue Per Share | 6.41 | 5.7 |
Pair Trading with Bionovate Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionovate Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionovate Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Bionovate Stock
Moving against Bionovate Stock
The ability to find closely correlated positions to Bionovate Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionovate Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionovate Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionovate Technologies Corp to buy it.
The correlation of Bionovate Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionovate Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionovate Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionovate Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Bionovate Technologies Basic Forecasting Models to cross-verify your projections. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Will Health Care Equipment & Supplies sector continue expanding? Could Bionovate diversify its offerings? Factors like these will boost the valuation of Bionovate Technologies. Projected growth potential of Bionovate fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bionovate Technologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Bionovate Technologies's market price often diverges from its book value, the accounting figure shown on Bionovate's balance sheet. Smart investors calculate Bionovate Technologies' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bionovate Technologies' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bionovate Technologies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bionovate Technologies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bionovate Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.